Article
The prognostic effects of somatic mutations in ER-positive breast cancer
2017-12-19
Abstract excerpt
More than 50 genes are recurrently affected by somatic mutation in estrogen receptor positive (ER+) breast cancer but prognostic effects have not been definitively established. Primary tumor DNA was therefore subjected to targeted sequencing from 625 postmenopausal (UBC-TAM series) and 328 premenopausal (MA12 trial) hormone receptor-positive (HR+) patients. Independent validation of prognostic interactions was ach...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5042a187-1ddb-568b-aa7f-d75e080b4632
- DOI
- 10.1101/235846
